Middle East Pharmaceutical Industries Co.

Last Updated:
  • 62.20 SAR
  • -0.95
  • -1.50%
شركة الشرق الأوسط للصناعات الدوائية
أفالون فارما
Symbol : 4016
ISIN : SA160G51UO10
Day Range : -
Turnover Ratio : 0.70
Market : Saudi Exchange
Sector : Pharma, Biotech & Life Science
Latest Announcements
2026-09-17 12:43:00.0Middle East Pharmaceutical Industries Co. Announces the renewal of a Shariah-compliant Bank facility agreement with Banque Saudi Fransi.
2026-08-20 05:00:00.0Middle East Pharmaceutical Industries Co announces the renewal of a Shariah-compliant credit facility agreement with Alinma Bank.
2026-08-18 05:01:00.0Middle East Pharmaceutical Industries Co. Announces Contract Sign Off with Bio-Thera Solutions Inc. A global biopharmaceutical company specializing in innovative biologics and biosimilars
2026-08-10 05:43:00.0Middle East Pharmaceutical Industries Co. announces the board of director’s decision to distribute cash dividends for the first half of 2026.
2026-08-06 05:03:00.0Middle East Pharmaceutical Industries Co. announces its Interim Financial results for the Period Ending on 2026-06-30 (Six Months)

Middle East Pharmaceutical Industries Co. Stock Overview

View Company Profile

Stock Summary

Last Price (SAR) 62.20
Prev. Close 62.200
Day Range 61.90 - 63.30
52WK range
Turnover (M SAR) 2.57
Volume (M) 0.04
Number of Trades 548
Market Cap (M SAR) 2,177.00
Change in Market Cap (M SAR)
VWAP (SAR) 0.00
EPS (TTM) --
EX-Dividend Date
Dividend
Dividend Yield (%)
Beta
30D Avg Volume
30D Avg Turnover(M SAR)
Outstanding Shares
Free Float Shares
Free Float %

Stock Performance

Stock Highlights

Highest Market Cap
Date of Highest Mkt. Cap
Lowest Market Cap
Date of Lowest Mkt. Cap
View Advanced Chart

Earnings Progress

Date Provider Title Category File
Date Provider Title Category File
  • No Upcoming Events

Riyadh – Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) extended a Sharia-compliant banking facility agreement with Banque...

Riyadh – Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) renewed its Sharia-compliant banking facility agreement with Alinma...

Riyadh - Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) announced a net profit of SAR 55.70 million for the first half (H1) of...

Riyadh - Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) named Ahmad Shaher Al Tabbaa as the board’s Chairman for the next...

Riyadh - Mubasher: The Capital Market Authority (CMA) approved the request of Middle East Pharmaceutical Industries Company (Avalon Pharma) to...